Quick Fire Q&A: How Is Roche Future-Proofing Its Pipeline?
This article was originally published in Scrip
Executive Summary
Lesley Bester, global business development officer for infectious diseases at Roche Holdings and global spokesperson, Anja von Treskow, answered a speed round of eight questions during the BIO-Europe Spring partnering conference, held in Stockholm, Sweden, about how the big pharma incorporates external innovation into its business model and methods the company has for future-proofing its pipeline.